Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raha Pharmaceutical Industries is a Jordanian pharmaceutical company established in 1992, specializing in the development, manufacturing, and marketing of high-quality generic medicines. The company operates a state-of-the-art manufacturing facility in the Sahab Industrial Estate, Jordan, which is fully compliant with Good Manufacturing Practice (GMP) standards. Raha Pharma's extensive product portfolio spans multiple therapeutic areas, including cardiovascular health, central nervous system disorders, respiratory conditions, and anti-infectives. The company serves both the domestic Jordanian market and various export markets across the Middle East and North Africa (MENA) region. By focusing on affordable generic alternatives, Raha Pharma aims to improve healthcare accessibility and patient outcomes throughout the region. Their operations include formulation development, quality control, and large-scale production of solid and liquid dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raha Company.